AstraZeneca says antibody treatment failed in preventing Covid-19 in exposed patients

AZD7442 reduced the risk of developing symptomatic Covid-19 by 33% compared to a placebo

Comments

Popular posts from this blog

BJP’s victory in local body polls indicator of coming Assembly polls: Bommai

Should there be a lesson on Jinnah?: Karnataka K.S. Eshwarappa asks

Bengaluru: Bus conductor fails to return Rs 1; court orders BMTC to pay Rs 3K as compensation